Immix Biopharma, Inc. IMMX Lease Liability Payments - Due Year Three
Lease Liability Payments - Due Year Three at other companies
Other financials
Where this comes from
Reported directly by Immix Biopharma, Inc. in its filing.
Tagged under the XBRL concept us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree.
The official record: Immix Biopharma, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Immix Biopharma, Inc.'s lease liability payments - due year three.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Immix Biopharma, Inc.'s lease liability payments - due year three?
- Immix Biopharma, Inc. (IMMX) reported lease liability payments - due year three of $169.6K in Q1 2026.
- How has Immix Biopharma, Inc.'s lease liability payments - due year three changed year-over-year?
- Immix Biopharma, Inc.'s lease liability payments - due year three increased by 3.5% year-over-year, from $163.87K to $169.6K.
- What does lease liability payments - due year three mean?
- The contractual cash obligations for operating and finance leases due in the third year following the balance sheet date. This metric helps in mapping out the long-term fixed cost profile of the company. It is essential for evaluating the sustainability of lease-related cash outflows over a multi-year horizon.